ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

CD8+ Tissue Resident Memory T Cells Are Key Effector Cells in Intestinal Transplantation Patients with GvHD

O. Aguirre, B. Houlihan, A. Karabala, R. Girlanda, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer.

Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.

Meeting: 2018 American Transplant Congress

Abstract number: 85

Keywords: Graft-versus-host-disease, Intestinal transplantation, T cells

Session Information

Session Name: Concurrent Session: Small Bowel: All Topics

Session Type: Concurrent Session

Date: Sunday, June 3, 2018

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:06pm-3:18pm

Location: Room 210

A. As the pathophysiologic role of Tissue Resident Memory T Cells (TRM) in intestinal transplantation (ITx) is unknown, this study aims to test the hypothesis that TRM play a critical effector role in graft-versus-host disease (GvHD) in ITx patients.

B. A cohort of 16 recent ITx patients was prospectively immunomonitored via serial blood and allograft polychromatic flow cytometry (PFC) starting one day before ITx. Five patients with clinically and pathologically confirmed GvHD were identified with onsets between (40-59, mean=46) days after ITx. CD3+ TRM cells were phenotypically defined as CD62L–CD45RO+/-CD69+CD103+/-, effector memory T cells (TEM) as CD45RO+CD62L– or CCR7–CD45RA–.

C. Importantly, immunomonitoring results revealed significantly higher frequencies of allograft CD8+ TRM (68.2%) with an effector memory phenotype in the GvHD group versus the stable ITx cohort (23.9%)(p=0.0065) at the time of GvHD diagnosis. This was accompanied by a trend towards lower mean frequencies of allograft CD4+ TRM in GvHD versus stable ITx patients (12.7% vs. 31.0%, p>0.05). Moreover, immunophenotyping of pre-reperfusion backtable samples confirmed the predominance of donor effector memory type CD8+ TRM (81.3%) in the allografts of GvHD patients prior to ITx. Thus, allograft-derived CD8+ TRM may be critical effector cells which, after engraftment and recirculation, initiate the process of GvHD. This hypothesis was corroborated by serial blood immunomonitoring which demonstrated an increase in CD8+ TEM immediately prior to presentation of GvHD (56%) versus pre-GvHD baseline (26%).

D. Prospective immunomonitoring indicates that donor allograft derived effector memory type CD8+ TRM may re-circulate after ITx and operate as effectors of GvHD, which may have important diagnostic and therapeutic implications.

CITATION INFORMATION: Aguirre O., Houlihan B., Karabala A., Girlanda R., Hawksworth J., Matsumoto C., Zasloff M., Fishbein T., Kroemer A. CD8+ Tissue Resident Memory T Cells Are Key Effector Cells in Intestinal Transplantation Patients with GvHD Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Aguirre O, Houlihan B, Karabala A, Girlanda R, Hawksworth J, Matsumoto C, Zasloff M, Fishbein T, Kroemer A. CD8+ Tissue Resident Memory T Cells Are Key Effector Cells in Intestinal Transplantation Patients with GvHD [abstract]. https://atcmeetingabstracts.com/abstract/cd8-tissue-resident-memory-t-cells-are-key-effector-cells-in-intestinal-transplantation-patients-with-gvhd/. Accessed May 11, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences